Vanda announces listing of a new HETLIOZ® patent in the FDA Orange Book
Vanda Pharmaceuticals announced that a HETLIOZ® patent, number 10,071,977 ('977 patent), is now listed in the FDA publication Approved Drug Products With Therapeutic Equivalence Evaluations, commonly known as the Orange Book. The '977 patent was issued by the USPTO on Sept. 11, 2018. September 20, 2018